Prevalence of dementia and mild cognitive impairment before incarceration

被引:5
|
作者
Kuffel, Randall L. [1 ,2 ]
Byers, Amy L. [1 ,2 ]
Williams, Brie [3 ]
Fortinsky, Richard [1 ]
Li, Yixia [1 ,2 ]
Ruderman, Michael A. [1 ,4 ]
Barry, Lisa C. [5 ,6 ]
机构
[1] San Francisco Vet Hlth Care Syst, San Francisco, CA USA
[2] Northern Calif Inst Res & Educ, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA
[5] Univ Connecticut, Ctr Aging, Sch Med, Farmington, CT 06030 USA
[6] Univ Connecticut, Dept Psychiat, Sch Med, 263 Farmington Ave, Farmington, CT 06030 USA
关键词
dementia; incarceration; jail; mild cognitive impairment; prisoners; FRONTOTEMPORAL DEMENTIA; CRIMINAL BEHAVIOR;
D O I
10.1111/jgs.17724
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Accumulating evidence indicates that behaviors in Alzheimer's disease and related dementias could result in incarceration. Yet, the proportion of persons diagnosed with dementia and mild cognitive impairment (MCI) before they were incarcerated is largely unknown. By leveraging a national sample of mid- to late-life adults who were incarcerated, we determined the prevalence of dementia and MCI before their incarceration. Methods In this current study, participants were Medicare-eligible U.S. veterans who transitioned from incarceration to the community in mid- to late-life from October 1, 2012, to September 30, 2018, after having been incarcerated for <= 10 consecutive years (N = 17,962). Medical claims data were used to determine clinical diagnoses of dementia and MCI up to three years before incarceration. Demographics, comorbidities, and duration of incarceration among those with dementia and MCI were compared to those with neither diagnosis. Results Participants were >97% male, 65% non-Hispanic white, 30% non-Hispanic black, and 3.3% had a diagnosis of either dementia (2.5%) or MCI (0.8%) before their most recent incarceration. Individuals with MCI or dementia diagnoses were older, were more likely to be non-Hispanic white, had more medical and psychiatric comorbidities, and experienced homelessness and traumatic brain injury at higher rates than those with neither diagnosis. Average duration of incarceration was significantly shorter among those with MCI (201.8 [+/- 248.0] days) or dementia (312.8 [+/- 548.3] days), as compared to those with neither diagnosis (497.0 [+/- 692.7] days) (p < 0.001). Conclusions These findings raise awareness of the proportion of incarcerated persons in the United States who have a diagnosis of MCI or dementia before they are incarcerated. Improved understanding of pathways linking cognitive impairment to incarceration in mid- to late-life are needed to inform appropriateness of incarceration, optimization of health care, and prevention of interpersonal harm in this medically vulnerable population.
引用
收藏
页码:1792 / 1799
页数:8
相关论文
共 50 条
  • [31] Neuropsychiatric symptoms in mild cognitive impairment and dementia: Prevalence and relationship to cognitive and functional impairment. The Cache County Study
    Tschanz, J
    Klein, E
    Treiber, K
    Corcoran, C
    Norton, M
    Toone, L
    Welsh-Bohmer, K
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S314 - S314
  • [32] The prevalence of dementia and cognitive impairment in China
    Ineichen, B
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 11 (08) : 695 - 697
  • [33] Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia
    Chertkow, Howard
    Massoud, Fadi
    Nasreddine, Ziad
    Belleville, Sylvie
    Joanette, Yves
    Bocti, Christian
    Drolet, Valerie
    Kirk, John
    Freedman, Morris
    Bergman, Howard
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 178 (10) : 1273 - 1285
  • [34] Use of Genetic Variation as Biomarkers for Mild Cognitive Impairment and Progression of Mild Cognitive Impairment to Dementia
    Reitz, Christiane
    Mayeux, Richard
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 229 - 251
  • [35] Forecasting the Prevalence of Alzheimer’s Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022
    Audrey Gabelle
    M. Guéry
    A. Doutriaux
    K. Bettayeb
    [J]. The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 259 - 266
  • [36] Forecasting the Prevalence of Alzheimer's Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022
    Gabelle, A.
    Guery, M.
    Doutriaux, A.
    Bettayeb, K.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (02): : 259 - 266
  • [37] Caregivers of People With Mild Cognitive Impairment and Dementia
    Meyer, Oanh L.
    Zheng, Shichen
    Alto, Raquel
    Tran, Duyen
    Luu, San
    Vu, Uyen
    Hinton, Ladson
    Harvey, Danielle
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2024, 38 (01): : 51 - 58
  • [38] Detection and Prevention of Mild Cognitive Impairment and Dementia
    Messinis, Lambros
    Nasios, Grigorios
    Ioannidis, Panagiotis
    Patrikelis, Panayiotis
    [J]. HEALTHCARE, 2023, 11 (16)
  • [39] Ketogenic therapies in mild cognitive impairment and dementia
    Cronje, Helene T.
    Jensen, Majken K.
    Rozing, Maarten P.
    Koch, Manja
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (05) : 330 - 332
  • [40] SELECTIVE UNAWARENESS OF COGNITIVE IMPAIRMENT IN MILD DEMENTIA
    Annoni, G.
    Umidi, S.
    Trimarchi, P. D.
    Menotti, M.
    [J]. GERONTOLOGIST, 2011, 51 : 303 - 304